Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
NeoVas BCS
DEVICE
3 trials
Sponsors
Lepu Medical Technology (Beijing) Co., Ltd.
Conditions
Coronary Artery Disease
Phase 1
NeoVas Bioresorbable Coronary Scaffold First-in-Man Study
NCT02195414
Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Artery Disease
Start: 2014-07-31
End: 2019-09-30
Updated: 2016-04-11
Unknown Phase
NeoVas Bioresorbable Coronary Scaffold Registry Study
NCT02305472
Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Artery Disease
Start: 2014-11-30
End: 2020-09-30
Target: 825
Updated: 2017-03-09
NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial
NCT02305485
Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Artery Disease
Start: 2014-11-30
End: 2020-06-30
Target: 560
Updated: 2016-12-08
Related Papers
5-Year Outcomes With a Novel Coronary Sirolimus-Eluting Bioresorbable Scaffold: The NeoVas Randomized Trial.
2025-09-01
A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting Stents.
2018-02-01
35 citations
1973Does the stent induced change in coronary geometry affect prognosis? Insights from 3-dimensional quantitative coronary angiographic analysis on the impact of vessel bending on coronary in-stent resten
European Heart Journal
2017-08-01
1 citations